Arkadios Wealth Advisors Amgen Inc Transaction History

Arkadios Wealth Advisors

$1.71 Billion
Q4 2024

A detailed history of Arkadios Wealth Advisors transactions in Amgen Inc stock. As of the latest transaction made, Arkadios Wealth Advisors holds 3,823 shares of AMGN stock, worth $1.12 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,823

Previous 3,929 2.7%

Holding current value

$1.12 Million

Previous $1.27 Million 21.26%

% of portfolio

0.06%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$258.78 - $328.31 $27,430 - $34,800	-106 Reduced 2.7%	3,823 $996,000
Q3 2024 Oct 24, 2024	BUY	$309.38 - $337.38 $66,516 - $72,536	215 Added 5.79%	3,929 $1.27 Million
Q2 2024 Jul 29, 2024	BUY	$262.75 - $319.31 $104,049 - $126,446	396 Added 11.93%	3,714 $1.16 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $7,797 - $9,412	29 Added 0.88%	3,318 $943,000
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $5,881 - $6,634	-23 Reduced 0.69%	3,289 $947,000
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $136,656 - $169,662	625 Added 23.26%	3,312 $890,000
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $642 - $760	-3 Reduced 0.11%	2,687 $596,000
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $27,094 - $33,024	120 Added 4.67%	2,690 $650,000
Q4 2022 Jan 11, 2023	SELL	$229.03 - $291.01 $14,886 - $18,915	-65 Reduced 2.47%	2,570 $0
Q3 2022 Oct 21, 2022	BUY	$224.46 - $253.15 $50,503 - $56,958	225 Added 9.34%	2,635 $594,000
Q2 2022 Jul 14, 2022	SELL	$230.71 - $256.74 $37,144 - $41,335	-161 Reduced 6.26%	2,410 $586,000
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $175,635 - $194,298	-801 Reduced 23.75%	2,571 $622,000
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $23,268 - $26,629	117 Added 3.59%	3,372 $759,000
Q3 2021 Oct 19, 2021	SELL	$212.27 - $248.7 $595,841 - $698,100	-2,807 Reduced 46.3%	3,255 $692,000
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $958,378 - $1.06 Million	4,103 Added 209.44%	6,062 $1.48 Million
Q1 2021 Apr 26, 2021	BUY	$221.91 - $258.6 $189,733 - $221,103	855 Added 77.45%	1,959 $487,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $140,214 - $166,970	648 Added 142.11%	1,104 $254,000
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $5,934 - $7,282	30 Added 7.04%	456 $116 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $4,373 - $5,800	24 Added 5.97%	426 $86.4 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $76,062 - $97,766	402 New	402 $96,000

Others Institutions Holding AMGN

# of Institutions

3,161

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.

Account

Arkadios Wealth Advisors Amgen Inc Transaction History